{"name":"Eric Simpson","slug":"eric-simpson","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Dupilumab Only Product","genericName":"Dupilumab Only Product","slug":"dupilumab-only-product","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Dupilumab Only Product","genericName":"Dupilumab Only Product","slug":"dupilumab-only-product","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE1pRnF1VHA2bGhlT25KWFZFSVhsN0EwSG5hcEh0SFNJcHBuU1Ixa2tIRExGelRXUmh1RzFmR3o5dmVyV2tpVXFXc2VpdFpCYTlQajctb09ubDV2YzdSb3M1a2hVSQ?oc=5","date":"2025-11-11","type":"pipeline","source":"Wiley Online Library","summary":"Journal of the European Academy of Dermatology and Venereology - Wiley Online Library","headline":"Journal of the European Academy of Dermatology and Venereology","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-31","type":"pipeline","source":"The Economic Times","summary":"Jessica Simpson and Eric Johnson back together months after separation? Ex-couple spotted at Ashlee Simpso - The Economic Times","headline":"Jessica Simpson and Eric Johnson back together months after separation? Ex-couple spotted at Ashlee Simpso","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-31","type":"pipeline","source":"The Times of India","summary":"Jessica Simpson and Eric Johnson spark reconciliation rumors; jet off to Las Vegas together - Deets insid - The Times of India","headline":"Jessica Simpson and Eric Johnson spark reconciliation rumors; jet off to Las Vegas together - Deets insid","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOUkZIMS1LQ0d4NkR3WGwxdkNXa1IwME5wYUZiM3dob19odlRzWHJtNllDRThwTGNQVS00ckFYcHlKcUtRQ0sxcDZySmZINGhsZmg0Y1NucHE1SkZmRDJPN3Rnd0lza01Ma0t3c01VQlZZSzdIc0pCVUpfZ2lSdF9yR0U0V2NDNkZwX0lfb0trRllJU2tnRENqOFFyU3BoQ0MxdElYWG1Da0ZfSzQzNHMxbXh0c3FNT1REdWR4alg1OXJScjFGNFE?oc=5","date":"2023-11-29","type":"pipeline","source":"European Medical Journal","summary":"ADVENT Symposia Highlights at EADV 2023 - European Medical Journal","headline":"ADVENT Symposia Highlights at EADV 2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE8zNTlRbE1weUxwU2szUk9lXzZWcElINURmNEJ5TDEtRThXd3RMcXhnNlhTUl9mZU1zQVBsZ1dpSGF1dGJtVTlaVlllMmJBOVI3aUZwWkVyQ0cwZFBqNGFGZzBzU2p3a0lLVEE?oc=5","date":"2023-07-16","type":"pipeline","source":"Wiley Online Library","summary":"Tralokinumab therapy for moderate-to-severe atopic dermatitis: Clinical outcomes with targeted IL-13 inhibition - Wiley Online Library","headline":"Tralokinumab therapy for moderate-to-severe atopic dermatitis: Clinical outcomes with targeted IL-13 inhibition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQQVhZTlZBTklhcHBObE45MDNGMWxHdmxiYlFIckliYzZDZmlIcFk1U3M1UHgxM25IWmV1Nk5RRjJLYlNmdFBtaU82OW5UTDA2Uko1djF4d0ZZWkVtbjBXVG1hRGR0amlaUzl5UEUzaEwyQVA1V2lxTF9DbEFWelBLOEF4bjBpMHhTdFFRN1BxLURxajZNRGlQaDNVeVJVMDBWdnc2X3JVaWtQT3pZOE5wUzdaVm9EbzJpOXZEZDFoRmdvUHVIQ0ZGU1BpVlRzTDFjMEk3MHBR?oc=5","date":"2022-11-08","type":"trial","source":"Healio","summary":"Safety data show Adbry well tolerated in treatment of moderate to severe atopic dermatitis - Healio","headline":"Safety data show Adbry well tolerated in treatment of moderate to severe atopic dermatitis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE41NzV3aTNCS29UV3lqa3ZpcVNnbXZMWjdJRWh0OVdYa1V2Wlp2N2RibmZaUV85NGo2VXNuYlFfUERZX25Sa1VnS283MUh6TEhicUdkcF9lZ0FDRzE3WVV2amg1YWE5VEtWc3JpSkJ3X29hMGFGdWMwUjJzQUw3dWc?oc=5","date":"2022-08-11","type":"pipeline","source":"Dermatology Times","summary":"When to Progress to Systemic Therapy - Dermatology Times","headline":"When to Progress to Systemic Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPNkVySVUzelRYWmJTbjc5SUg1S2NMSDBpNjZqT3ZjWEROcTBlNHJzUmpaYmFncklzVE1YeDZsV2lPRjlOTENYeS1RZEdiVll1Wm45c0JXRXBZc0hqdU81YVVLOWFraWFZREFWTXRmWXY5dFpCRFVVeVI2aE5vWXZhLTNYeWc5Y3NzUFhPN1dxVzNybUs1XzVZend1SC0zTTg5N1E5dmJSQjNHLVpZTThLR3VOSlFMQmJhMmZZZ2tQQQ?oc=5","date":"2022-04-20","type":"trial","source":"Pharmacy Times","summary":"Clinical Trial Results Show Lilly’s Lebrikizumab Improves Severity of Atopic Dermatitis - Pharmacy Times","headline":"Clinical Trial Results Show Lilly’s Lebrikizumab Improves Severity of Atopic Dermatitis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNVXdUX01JVklnQy10RUtoOGJDN2d5VV9lb25LdjdiYmo5R2dLY0Z5ei1kU2VmMnR5U1lCU29rd0M1MWF6aGdVdkQycEZ2c1RXVlJvSUdocFZQN1c1cDdtTk9GR3RpSVlVN2ptRFRCTVFTUDJMa3FtWGgwOFlhS2poLVlCQXd2QTh1RVhwVEMzUURuSk1GQ1NqMUVGUQ?oc=5","date":"2018-03-15","type":"pipeline","source":"APhA","summary":"Why I’m returning for my second annual meeting - APhA","headline":"Why I’m returning for my second annual meeting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPRVpGTWJOSXRrR2s4WkVWdXZlNy1QR09xTXBQa2RvV2tDdjlEY3hoZXBTUFNMYXBEWXdzUkFYQzZTV2o5VTJsYjY0T3NGNnd1djc3czhwbUhWd3RJUGZ4ZWg3NHFvcjJDcGZCNjRoWEJHbFhoSjBfMDNLdFE5NkJjTFlwNWtVek9TZWZ1NDVXUQ?oc=5","date":"2016-10-03","type":"regulatory","source":"OHSU News","summary":"Targeted drug tames atopic eczema in Phase III trials - OHSU News","headline":"Targeted drug tames atopic eczema in Phase III trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQS3pQUC05UVJmOWFsMEJZZVZqcEgxOHcyWEVHdE4wZ2E3MmxBZUdlOEc5c2xlbGs5YzYxWWs0Q0haRUt5bzR3UVJHeDNQcTk3a3RIV3U5MW5FOGU1b3NLSHRrZUlZQmdVT2xzMlo1ZGctNUF5VkdhVHdlVVpqUV85NEdpbzVvQ0ZoQnRwUVNrRQ?oc=5","date":"2016-10-03","type":"pipeline","source":"BioPharma Dive","summary":"Regeneron and Sanofi tout dupilumab success - BioPharma Dive","headline":"Regeneron and Sanofi tout dupilumab success","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTFBORExZYVRvZlBNd1d5RmhfYUNRSUUtMVRUeTF4cjQzQ2dXZnhzQzBqd1ZSUVQ2djBoWC1pUjlTU3JFQ1pDOUZ0Mnk0TGluRV9JSF95MTZaVzgxa1VJRzdOYg?oc=5","date":"2016-10-01","type":"trial","source":"NEJM","summary":"Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis - NEJM","headline":"Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}